Zhenghai Biotech announced that in order to further enrich the company's R&D pipeline and expand the product matrix, the company recently signed a “Technology Development Contract” with the trustee, the Institute of Biotechnology of the Chinese Academy of Agricultural Sciences for the “Research and Development of Recombinant Type III Collagen Products” project. The total contract amount is 12 million yuan, and specific payments will be made according to the milestone points agreed in the contract.

Zhenghai Biotech announced that in order to further enrich the company's R&D pipeline and expand the product matrix, the company recently signed a “Technology Development Contract” with the trustee, the Institute of Biotechnology of the Chinese Academy of Agricultural Sciences for the “Research and Development of Recombinant Type III Collagen Products” project. The total contract amount is 12 million yuan, and specific payments will be made according to the milestone points agreed in the contract.